We are live on ! Find out more
Primecap Management

Primecap Management Portfolio holdings

AUM $169B Turnover 4.85%
1-Year Est. Return 114.72%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$149B
AUM Growth
+$5.43B
Cap. Flow
-$4.27B
Cap. Flow %
-2.87%
Top 10 Hldgs %
30.32%
Holding
338
New
11
Increased
51
Reduced
229
Closed
5
Avg Time Held
4.7 years
Top 10 Avg Time Held
5 years
Top 20 Avg Time Held
4.3 years

Top Buys

Rank Stock Value
1
SPLK icon
Splunk Inc
SPLK
+$151M
2
BABA icon
Alibaba
BABA
+$115M
3
XPEV icon
XPeng
XPEV
+$79M
4
RJF icon
Raymond James Financial
RJF
+$71.4M
5
ALLO icon
Allogene Therapeutics
ALLO
+$64.8M

Sector Composition

Rank Sector Weight
1 Technology 30.47%
2 Healthcare 26.99%
3 Industrials 12.32%
4 Consumer Discretionary 10.96%
5 Financials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AVO icon
326
Mission Produce
AVO
$1.06B
$1.2M ﹤0.01%
58,108
-129,779
-69% -$2.65M
2020 Q4
2 quarters
MSGS icon
327
Madison Square Garden
MSGS
$9.74B
$1.17M ﹤0.01%
6,773
-100
-1% -$18.1K
2020 Q1
5 quarters
AWI icon
328
Armstrong World Industries
AWI
$7.04B
$1.07M ﹤0.01%
10,000
-12,000
-55% -$1.24M
2016 Q4
18 quarters
CELL
329
DELISTED
PhenomeX Inc. Common Stock
CELL
$970K ﹤0.01%
21,658
– –
2021 Q1
1 quarter
ANET icon
330
Arista Networks
ANET
$234B
$960K ﹤0.01%
42,400
-8,000
-16% -$167K
2014 Q2
28 quarters
ULCC icon
331
Frontier Group Holdings
ULCC
$1.16B
$954K ﹤0.01%
+56,000
New +$1.1M
2021 Q2
0 quarters
PDAC
332
DELISTED
Peridot Acquisition Corp.
PDAC
$448K ﹤0.01%
+36,800
New +$395K
2021 Q2
0 quarters
SIOX
333
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$143K ﹤0.01%
52,325
– –
2015 Q2
24 quarters
ANGI icon
334
Angi Inc
ANGI
$262M
– –
-11,500
Closed -$1.5M –
LGF.B
335
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
– –
-592,900
Closed -$7.65M –
TPCO
336
DELISTED
Tribune Publishing Company Common Stock
TPCO
– –
-198,500
Closed -$3.57M –
PRSP
337
DELISTED
Perspecta Inc. Common Stock
PRSP
– –
-580,564
Closed -$16.9M –
PS icon
338
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
– –
-189,400
Closed -$4.23M –

Similar funds

Primecap Management's Q2 2021 Portfolio in Review

As of Q2 2021, Primecap Management held 338 positions worth $149B, up 3.8% from $143B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 4.7%. Primecap Management opened 11 new positions and exited 5, leaving the 338-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Primecap Management's largest Q2 2021 buy was Xometry: 300,000 shares worth $26.2M.
  • Primecap Management added most to Splunk Inc in Q2 2021, an estimated $151M increase.
  • Primecap Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $285M.
  • Primecap Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $16.9M.
  • Primecap Management's ten largest holdings make up 30% of its $149B portfolio in Q2 2021.
  • Primecap Management opened 11 new positions and closed 5 in Q2 2021.
  • Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $149B.

Based on Primecap Management's 13F filing for Q2 2021, filed 10 Aug 2021.